HK1117402A1 - Use of [2-(2-methylimidazol-1-yl)methyl]pyridine for treating sleep disorders - Google Patents
Use of [2-(2-methylimidazol-1-yl)methyl]pyridine for treating sleep disordersInfo
- Publication number
- HK1117402A1 HK1117402A1 HK08108222.5A HK08108222A HK1117402A1 HK 1117402 A1 HK1117402 A1 HK 1117402A1 HK 08108222 A HK08108222 A HK 08108222A HK 1117402 A1 HK1117402 A1 HK 1117402A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methylimidazol
- pyridine
- methyl
- sleep disorders
- treating sleep
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70360405P | 2005-07-29 | 2005-07-29 | |
US73253605P | 2005-11-02 | 2005-11-02 | |
PCT/US2006/029112 WO2007016203A1 (en) | 2005-07-29 | 2006-07-26 | Method of improving wakefulness |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1117402A1 true HK1117402A1 (en) | 2009-01-16 |
Family
ID=37708941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08108222.5A HK1117402A1 (en) | 2005-07-29 | 2008-07-24 | Use of [2-(2-methylimidazol-1-yl)methyl]pyridine for treating sleep disorders |
Country Status (12)
Country | Link |
---|---|
US (1) | US20080280954A1 (xx) |
EP (1) | EP1919477B1 (xx) |
JP (1) | JP5017268B2 (xx) |
KR (2) | KR101187461B1 (xx) |
AU (1) | AU2006275824B2 (xx) |
BR (1) | BRPI0614701A2 (xx) |
CA (1) | CA2616177C (xx) |
ES (1) | ES2388876T3 (xx) |
HK (1) | HK1117402A1 (xx) |
NO (1) | NO20080993L (xx) |
NZ (1) | NZ565763A (xx) |
WO (1) | WO2007016203A1 (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101394849A (zh) | 2006-02-13 | 2009-03-25 | Vanda制药公司 | 咪唑基烷基-吡啶的稳定的剂量制剂 |
KR101587394B1 (ko) * | 2006-05-22 | 2016-01-21 | 반다 파마슈티칼즈, 인코퍼레이티드. | 멜라토닌 효능제 치료 |
WO2009097414A1 (en) * | 2008-01-29 | 2009-08-06 | Vanda Pharmaceuticals, Inc. | Use of imidazolylalkyl-pyridines for the treatment of addictive disorders |
US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
KR102317399B1 (ko) | 2012-01-26 | 2021-10-26 | 반다 파마슈티칼즈, 인코퍼레이티드. | 일주기 리듬 장애의 치료 |
EP2861244B1 (en) * | 2012-06-14 | 2018-09-19 | The Regents Of The University Of Michigan | Sleep apnea treatment |
CN105142630A (zh) | 2012-12-18 | 2015-12-09 | 万达制药公司 | 昼夜节律紊乱的治疗 |
CN103087019B (zh) * | 2013-02-06 | 2015-02-04 | 济南志合医药科技有限公司 | 一种他司美琼的制备方法 |
US10376487B2 (en) | 2013-11-12 | 2019-08-13 | Vanda Pharmaceuticals Inc. | Method of treatment |
US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2593809B1 (fr) * | 1986-01-31 | 1988-07-22 | Lafon Labor | Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique |
DE4131584A1 (de) * | 1991-09-23 | 1993-03-25 | Sandoz Ag | Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika |
US5635521A (en) * | 1991-09-23 | 1997-06-03 | Sandoz Ltd. | Imidazolylmethyl-pyridines |
NZ330656A (en) | 1996-03-08 | 1999-06-29 | Takeda Chemical Industries Ltd | Tricyclic compounds, their production and use |
US20010034373A1 (en) * | 2000-02-09 | 2001-10-25 | Matthew Miller | Low dose modafinil for enhancement of cognitive function |
GB0009037D0 (en) | 2000-04-13 | 2000-05-31 | Novartis Ag | Organic compounds |
US20040048931A1 (en) * | 2002-07-12 | 2004-03-11 | Craig Heacock | Modafinil pharmaceutical compositions |
US7528172B2 (en) * | 2003-01-21 | 2009-05-05 | The Cooper Health System, Inc. | Compositions and methods for improving recovery after general anesthesia |
-
2006
- 2006-07-26 KR KR1020117001250A patent/KR101187461B1/ko not_active IP Right Cessation
- 2006-07-26 ES ES06774700T patent/ES2388876T3/es active Active
- 2006-07-26 US US11/997,007 patent/US20080280954A1/en not_active Abandoned
- 2006-07-26 BR BRPI0614701-1A patent/BRPI0614701A2/pt not_active IP Right Cessation
- 2006-07-26 WO PCT/US2006/029112 patent/WO2007016203A1/en active Application Filing
- 2006-07-26 AU AU2006275824A patent/AU2006275824B2/en not_active Ceased
- 2006-07-26 NZ NZ565763A patent/NZ565763A/en not_active IP Right Cessation
- 2006-07-26 JP JP2008524131A patent/JP5017268B2/ja not_active Expired - Fee Related
- 2006-07-26 CA CA2616177A patent/CA2616177C/en not_active Expired - Fee Related
- 2006-07-26 KR KR1020087002587A patent/KR101146807B1/ko not_active IP Right Cessation
- 2006-07-26 EP EP06774700A patent/EP1919477B1/en active Active
-
2008
- 2008-02-25 NO NO20080993A patent/NO20080993L/no not_active Application Discontinuation
- 2008-07-24 HK HK08108222.5A patent/HK1117402A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20080280954A1 (en) | 2008-11-13 |
JP2009502945A (ja) | 2009-01-29 |
WO2007016203A1 (en) | 2007-02-08 |
KR101146807B1 (ko) | 2012-05-21 |
KR101187461B1 (ko) | 2012-10-02 |
EP1919477A4 (en) | 2009-03-18 |
CA2616177A1 (en) | 2007-02-08 |
JP5017268B2 (ja) | 2012-09-05 |
AU2006275824B2 (en) | 2010-12-16 |
KR20080033322A (ko) | 2008-04-16 |
EP1919477A1 (en) | 2008-05-14 |
EP1919477B1 (en) | 2012-07-11 |
CA2616177C (en) | 2012-05-01 |
KR20110011748A (ko) | 2011-02-08 |
BRPI0614701A2 (pt) | 2011-04-12 |
NZ565763A (en) | 2010-12-24 |
ES2388876T3 (es) | 2012-10-19 |
NO20080993L (no) | 2008-02-25 |
AU2006275824A1 (en) | 2007-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1117402A1 (en) | Use of [2-(2-methylimidazol-1-yl)methyl]pyridine for treating sleep disorders | |
IL192241A (en) | A process for making 4 - (benzimidazolylmethylamino) - benzamides and their salts | |
HK1130776A1 (en) | Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders | |
PL1701944T3 (pl) | (2-Amino-podstawione)-4-arylopirymidyny i związki pokrewne, użyteczne do leczenia chorób zapalnych | |
ZA200804198B (en) | Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides | |
ZA200700384B (en) | Hydantoin derivatives for the treatment of inflammatory disorders | |
ZA200706791B (en) | Isoxazole combretasin derivatives for the treatment of disorders | |
ZA200806072B (en) | Hydantoin derivatives for the treatment of inflammatory disorders | |
IL187302A0 (en) | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia | |
IL192885A0 (en) | Use of 4-imidazole derivatives for cns disorders | |
AU2008281877A8 (en) | The use of benzamide derivatives for the treatment of CNS disorders | |
ZA200801888B (en) | Derivatives of 4-piperazin-1-1-YL-4-benzo [B] thiophene suitable for the treatment of CNS disorders | |
EP1957077A4 (en) | SUBSTITUTED 4-AMINO-PYRROLOTRIAZIN DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE ILLNESSES AND DISEASES RELATED TO ANGIOGENESIS | |
HK1133426A1 (en) | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper- proliferative disorders and diseases associated with angiogenesis | |
IL185498A0 (en) | Pyrimidine derivatives for treatment of hyperproliferative disorders | |
EP1901733A4 (en) | USE OF HUPERZINE FOR DISEASES | |
ZA200710605B (en) | New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases | |
EP2139475A4 (en) | USE OF PDE7 INHIBITORS IN THE TREATMENT OF | |
ZA200708033B (en) | Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia | |
PL1793783T3 (pl) | Sposób wytwarzania jednorazowych wyrobów chłonnych | |
IL197695A0 (en) | 3-amino-pyridine derivatives for the treatment of metabolic disorders | |
ZA200901015B (en) | Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders | |
IL192933A0 (en) | Benzoisoindole derivatives for the treatment of pain | |
GB0604780D0 (en) | Use of substituted piperazine compounds for the treatment of food related disorders | |
IL209417A0 (en) | 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160726 |